Asia Pacific Bone Grafts And Substitutes Market Size & Outlook
Asia Pacific bone grafts and substitutes market, 2017-2030 (US$M)
Related Markets
Asia Pacific bone grafts and substitutes market highlights
- The Asia Pacific bone grafts and substitutes market generated a revenue of USD 576.0 million in 2022.
- The market is expected to grow at a CAGR of 7.9% from 2023 to 2030.
- In terms of segment, synthetic was the largest revenue generating material type in 2022.
- Allograft is the most lucrative material type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2023 to 2030.
Asia Pacific data book summary
| Market revenue in 2022 | USD 576.0 million |
| Market revenue in 2030 | USD 1,057.5 million |
| Growth rate | 7.9% (CAGR from 2022 to 2030) |
| Largest segment | Synthetic |
| Fastest growing segment | Allograft |
| Historical data covered | 2017 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Allograft, Synthetic |
| Key market players worldwide | DePuy Synthes, Baxter International Inc, NuVasive, Smith & Nephew PLC, Medtronic PLC, Orthofix Medical Inc, Zimmer Biomet Holdings Inc, Geistlich Pharma, Stryker Corp, AlloSource, TBF, OST Laboratoires, Biobank |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 20.5% of the global bone grafts and substitutes market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,057.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Bone Grafts And Substitutes Market Scope
Bone Grafts And Substitutes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific bone grafts and substitutes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bone grafts and substitutes market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 60.8% in 2022. Horizon Databook has segmented the Asia Pacific bone grafts and substitutes market based on allograft, synthetic covering the revenue growth of each sub-segment from 2017 to 2030.
Asia Pacific region is expected to show lucrative growth over the forecast period. The growth can be attributed to increased number of medical tourism and government initiatives. Moreover, growing ageing population in this region is further increasing the risk of bone diseases and joint problems.
On a contrary, stringent regulatory guidelines in some of the countries limit the growth of this region. In South Korea, the product should be approved by the Korean Food and Drug Administration (KFDA). In case of Australia the products are regulated by Therapeutic Goods Administration (TGA).
The stringent regulatory scenario in Japan may restraint the growth in the coming years. Geistlich is one of the major companies for dental xenograft products in this region. Medical tourism in India for grafting surgery is another growth propelling factor for the market.
Reasons to subscribe to Asia Pacific bone grafts and substitutes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific bone grafts and substitutes market databook
-
Our clientele includes a mix of bone grafts and substitutes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific bone grafts and substitutes market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific bone grafts and substitutes market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific bone grafts and substitutes market size, by country, 2017-2030 (US$M)
Asia Pacific Bone Grafts And Substitutes Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
